Division of Cardiovascular Surgery, Children's National Heart Institute, Children's National Hospital, Washington, DC.
Division of Cardiology, Children's National Heart Institute, Children's National Hospital, Washington, DC.
J Thorac Cardiovasc Surg. 2024 Oct;168(4):1221-1227.e1. doi: 10.1016/j.jtcvs.2024.04.013. Epub 2024 Apr 28.
The association between the prevalence of cirrhosis and the types of Fontan operations remains unclear.
We conducted a retrospective chart review of 332 patients who underwent the Fontan procedure at our institution. Four patients who underwent the atriopulmonary connection Fontan were excluded from the analysis. Patients who had intracardiac-extracardiac conduit (126) between 1989 and 2021 were pooled with those having extracardiac conduit (ECC) (134). The 260 patients who underwent the ECC and the 68 patients who had the lateral tunnel (LT) Fontan constitute the core of the study.
Median age at the Fontan procedure was 23.7 months (interquartile range [IQR], 20.8-32.6) in the LT group, compared with 28.8 months (IQR, 24.6-39.5) in the ECC group (P < .01). The median follow-up was 14.8 years (IQR, 12.5-16.5) in the LT group and 7 years (IQR, 2.8-10.4) in the extracardiac conduit group. During the follow-up period, 3 patients (4.4%) with LT and 17 patients (6.5%) with ECC (11 patients with 16 mm or less conduit size) were diagnosed with cirrhosis. The prevalence of cirrhosis at 1, 5, 10, and 15 years was 0%, 0%, 0%, and 4.4% in the LT group, respectively, and 0%, 0.9%, 7.7%, and 29.8% in the ECC group (P < .01) Rates of mortality, Fontan revision, Fontan takedown, transplant, and complications were comparable between the 2 groups.
The extracardiac conduit Fontan seems to be associated with faster development of cirrhosis.
肝硬化的患病率与 Fontan 手术类型之间的关系尚不清楚。
我们对在我院行 Fontan 手术的 332 例患者进行了回顾性图表分析。4 例接受房-肺动脉连接 Fontan 手术的患者被排除在分析之外。将 1989 年至 2021 年间接受心外管道(126 例)和心外管道(ECC)(134 例)的患者进行了汇总。260 例接受 ECC 的患者和 68 例接受侧隧道(LT)Fontan 的患者构成了本研究的核心。
在 LT 组,Fontan 手术时的中位年龄为 23.7 个月(四分位距[IQR],20.8-32.6),而 ECC 组为 28.8 个月(IQR,24.6-39.5)(P<.01)。LT 组的中位随访时间为 14.8 年(IQR,12.5-16.5),ECC 组为 7 年(IQR,2.8-10.4)。在随访期间,3 例(4.4%)LT 患者和 17 例(6.5%)ECC 患者(11 例为 16 毫米或更小的管道大小)被诊断为肝硬化。LT 组肝硬化的 1、5、10 和 15 年的患病率分别为 0%、0%、0%和 4.4%,ECC 组分别为 0%、0.9%、7.7%和 29.8%(P<.01)。两组的死亡率、Fontan 修复、Fontan 切除、移植和并发症发生率相似。
ECC Fontan 似乎与肝硬化的快速发展有关。